Difference between revisions of "Team:SZU China/Basic parts"
(11 intermediate revisions by 4 users not shown) | |||
Line 27: | Line 27: | ||
<br> | <br> | ||
<br> | <br> | ||
− | <p id="heading" | + | <p id="heading">Basic parts</p> |
</div></br> | </div></br> | ||
<br> | <br> | ||
Line 46: | Line 46: | ||
<div class="part_info"> | <div class="part_info"> | ||
<p><a href="http://parts.igem.org/Part:BBa_K1722000">BBa_K1722000</a><br> | <p><a href="http://parts.igem.org/Part:BBa_K1722000">BBa_K1722000</a><br> | ||
− | + | hUPll is a bladder tissue-specific promoter being found in human urothelium. Uroplakin II (UPII) has been characterized as a bladder tissue-specific protein and the expression of uroplakin II was found to be limited to bladder-derived cells. 2015 SZU-iGEM use hUPII to drive the expression of the therapeutic genes(such as p21 and Bax) so that the gene is expressed only in bladder cells and systematic toxicity is minimized. | |
</p> | </p> | ||
</div> | </div> | ||
Line 55: | Line 55: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
<div class="part_name"> | <div class="part_name"> | ||
− | <h3><strong>Another Basic Part :</strong> | + | <h3><strong>Another Basic Part :</strong> hTERT</h3> |
</div> | </div> | ||
<div class="part_info"> | <div class="part_info"> | ||
<p><a href="http://parts.igem.org/Part:BBa_K1722002">BBa_K1722002</a><br> | <p><a href="http://parts.igem.org/Part:BBa_K1722002">BBa_K1722002</a><br> | ||
− | + | hTERT, which is short for human telomerase reverse transcriptase, is recognized as a cancer specific promoter for various cancers. Researches show that hTERT promoters are activated in tumor cells that are telomerase positive while being inhibited in normal cells that are telomerase negative, which indicates that hTERT promoter may specifically target at tumor cells. | |
</p> | </p> | ||
</div> | </div> | ||
Line 70: | Line 70: | ||
<div class="part_info"> | <div class="part_info"> | ||
<p><a href="http://parts.igem.org/Part:BBa_K1722004">BBa_K1722004</a><br> | <p><a href="http://parts.igem.org/Part:BBa_K1722004">BBa_K1722004</a><br> | ||
− | + | This tRNA gene can produce an tRNA with CUA as its anticodon, which can pair with the amber mutated stop codon UAG in the mRNA chain to continue the translation of the amber mutated mRNA. Only with this tRNA can the mRNA chain with UAG terminator being fully translated. The aminoacyl-tRNA came from barchaebacteria, and it is generally applied to unnatural amino acid orthogonal system. | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
</div></br> | </div></br> | ||
− | + | ||
− | + | ||
</div> | </div> | ||
Line 86: | Line 85: | ||
− | + | <div class="col-sm-4"> | |
− | + | <div class="part_name"> | |
− | + | <h3><strong>Another Basic Part :</strong> shTERT</h3> | |
− | + | </div> | |
<div class="part_info"> | <div class="part_info"> | ||
− | + | <p><a href="http://parts.igem.org/Part:BBa_K1722001">BBa_K1722001</a><br> | |
− | + | shTERT is short for super human telomerase reverse transcriptase, which is improved from hTERT promoter(<a href="http://parts.igem.org/Part:BBa_K404106">BBa_K404106</a>), a cancer specific promoter. Three base pairs in hTERT promoter were mutated and the drive efficiency of the promoter was verified to be increased significantly. | |
</p> | </p> | ||
</div> | </div> | ||
Line 101: | Line 100: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
<div class="part_name"> | <div class="part_name"> | ||
− | <h3><strong>Another Basic Part :</strong> | + | <h3><strong>Another Basic Part :</strong> Rluc</h3> |
</div> | </div> | ||
<div class="part_info"> | <div class="part_info"> | ||
− | <p><a href="http://parts.igem.org/Part: | + | <p><a href="http://parts.igem.org/Part:BBa_K1722005">BBa_K1722005</a><br> |
− | + | The Rluc was improved from <a href="http://parts.igem.org/Part:BBa_J52012">BBa_J52012</a>,which was being amber mutated.It can be transcripted to an mRNA chain with one codon being mutated to stop codon UAG. It cannot be fully expressed in natural biology system but can be used as a reporter gene in unnatural amino acid orthogonal system which has a tRNA whose anticodon can pair with the stop codon. | |
</p> | </p> | ||
</div> | </div> | ||
Line 111: | Line 110: | ||
<div class="col-sm-4"> | <div class="col-sm-4"> | ||
− | + | <div class="part_name"> | |
− | + | <h3><strong>Another Basic Part :</strong> SV40</h3> | |
− | + | </div> | |
<div class="part_info"> | <div class="part_info"> | ||
− | + | <p><a href="http://parts.igem.org/Part:BBa_K1722006">BBa_K1722006</a><br> | |
− | + | Different from the SV40 promoter distributed by iGEM13_Freiburg(<a href="http://parts.igem.org/Part:BBa_K1150011">BBa_K1150011</a>), the promoter we are submitting this year includes an enhancer sequence(74bp) upstream of the promoter gene. It is a widely used strong promoter that can improve the gene expression level of many host cells. the therapeutic gene out. | |
</p> | </p> | ||
− | + | </div> | |
</div> | </div> | ||
− | + | </div></br> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | <div class=" | + | </div> |
− | <h3><strong>All our parts</strong></h3><br> | + | |
+ | <div class="container" style="padding:20px;"> | ||
+ | |||
+ | |||
+ | <div class="row"> | ||
+ | |||
+ | |||
+ | |||
+ | <div class="col-sm-4"> | ||
+ | <div class="part_name"> | ||
+ | <h3><strong>All our parts :</strong></h3> | ||
+ | <br> | ||
<a href="http://parts.igem.org/Part:BBa_K1722000">BBa_K1722000</a> : Hupll part<br> | <a href="http://parts.igem.org/Part:BBa_K1722000">BBa_K1722000</a> : Hupll part<br> | ||
<a href="http://parts.igem.org/Part:BBa_K1722001">BBa_K1722001</a> : shTERT part<br> | <a href="http://parts.igem.org/Part:BBa_K1722001">BBa_K1722001</a> : shTERT part<br> | ||
Line 142: | Line 145: | ||
<a href="http://parts.igem.org/Part:BBa_K1722011">BBa_K1722011</a> : shTERT+tRNA Composite<br> | <a href="http://parts.igem.org/Part:BBa_K1722011">BBa_K1722011</a> : shTERT+tRNA Composite<br> | ||
<a href="http://parts.igem.org/Part:BBa_K1722012">BBa_K1722012</a> : SV40(with enhancer)+Rluc Composite<br> | <a href="http://parts.igem.org/Part:BBa_K1722012">BBa_K1722012</a> : SV40(with enhancer)+Rluc Composite<br> | ||
− | <a href="http://parts.igem.org/Part:BBa_K1722013">BBa_K1722013</a> : Sv40+Rlu Composite<br> | + | <a href="http://parts.igem.org/Part:BBa_K1722013">BBa_K1722013</a> : Sv40+Rlu Composite<br> |
− | + | </div> | |
− | + | ||
− | + | ||
</div> | </div> | ||
− | |||
+ | |||
+ | <div class="col-sm-4"> | ||
+ | <div class="part_name"> | ||
+ | <h3><strong>Favorite parts :</strong> </h3> | ||
+ | <br> | ||
+ | <a href="http://parts.igem.org/Part:BBa_K1722007">BBa_K1722007</a> : hUPⅡ+AckRS Composite<br> | ||
+ | <a href="http://parts.igem.org/Part:BBa_K1722010">BBa_K1722010</a> : hTERT+tRNA Composite<br> | ||
+ | <a href="http://parts.igem.org/Part:BBa_K1722012">BBa_K1722012</a> : SV40(with enhancer)+Rluc Composite<br> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div><!-- /.row --> | </div><!-- /.row --> | ||
Line 163: | Line 181: | ||
</body> | </body> | ||
</html> | </html> | ||
+ | {{Template:SZU_China/Playground/footer}} |
Latest revision as of 22:46, 18 September 2015
Basic parts
New Basic Part : hUPll
BBa_K1722000
hUPll is a bladder tissue-specific promoter being found in human urothelium. Uroplakin II (UPII) has been characterized as a bladder tissue-specific protein and the expression of uroplakin II was found to be limited to bladder-derived cells. 2015 SZU-iGEM use hUPII to drive the expression of the therapeutic genes(such as p21 and Bax) so that the gene is expressed only in bladder cells and systematic toxicity is minimized.
Another Basic Part : hTERT
BBa_K1722002
hTERT, which is short for human telomerase reverse transcriptase, is recognized as a cancer specific promoter for various cancers. Researches show that hTERT promoters are activated in tumor cells that are telomerase positive while being inhibited in normal cells that are telomerase negative, which indicates that hTERT promoter may specifically target at tumor cells.
Another Basic Part : tRNA
BBa_K1722004
This tRNA gene can produce an tRNA with CUA as its anticodon, which can pair with the amber mutated stop codon UAG in the mRNA chain to continue the translation of the amber mutated mRNA. Only with this tRNA can the mRNA chain with UAG terminator being fully translated. The aminoacyl-tRNA came from barchaebacteria, and it is generally applied to unnatural amino acid orthogonal system.
Another Basic Part : shTERT
BBa_K1722001
shTERT is short for super human telomerase reverse transcriptase, which is improved from hTERT promoter(BBa_K404106), a cancer specific promoter. Three base pairs in hTERT promoter were mutated and the drive efficiency of the promoter was verified to be increased significantly.
Another Basic Part : Rluc
BBa_K1722005
The Rluc was improved from BBa_J52012,which was being amber mutated.It can be transcripted to an mRNA chain with one codon being mutated to stop codon UAG. It cannot be fully expressed in natural biology system but can be used as a reporter gene in unnatural amino acid orthogonal system which has a tRNA whose anticodon can pair with the stop codon.
Another Basic Part : SV40
BBa_K1722006
Different from the SV40 promoter distributed by iGEM13_Freiburg(BBa_K1150011), the promoter we are submitting this year includes an enhancer sequence(74bp) upstream of the promoter gene. It is a widely used strong promoter that can improve the gene expression level of many host cells. the therapeutic gene out.
All our parts :
BBa_K1722000 : Hupll part
BBa_K1722001 : shTERT part
BBa_K1722002 : hTERT part
BBa_K1722004 : tRNA part
BBa_K1722005 : Rlu part
BBa_K1722006 : SV40(with enhancer) part
BBa_K1722007 : hUPⅡ+AckRS Composite
BBa_K1722009 : hTERT+GFP Composite
BBa_K1722010 : hTERT+tRNA Composite
BBa_K1722011 : shTERT+tRNA Composite
BBa_K1722012 : SV40(with enhancer)+Rluc Composite
BBa_K1722013 : Sv40+Rlu Composite
Favorite parts :
BBa_K1722007 : hUPⅡ+AckRS Composite
BBa_K1722010 : hTERT+tRNA Composite
BBa_K1722012 : SV40(with enhancer)+Rluc Composite